BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Curis Lifesciences Ltd. IPO

IPO Date: Nov 7 to Nov 11 2025

Listing Date: Nov 14 2025

Objective

i.Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities;ii.Capital Expenditure towards Construction of a Storage Facility;iii.Pre-payment/Repayment of outstanding Secured Loans;iv.Product Registrations in other countries;v.Funding our Working Capital Requirements; andvi.General Corporate Purpose.

IPO Details

Face Value ₹ 10.00 Per Share
Issue Size ₹ 18.49 - 19.72 Cr
Price Band ₹ 120.00 - ₹ 128.00 Per Share
Market LOT 2000 shares
Issue Type Book building

About Company

Our business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic onloan license or contract Manufacturing and own brand marketing basis. Our business is majorly on principle to principlebasis with different marketers. As on the date of this Draft Red Herring Prospectus, we cater to more than 100 corporateclients on loan license and/or contract manufacturing basis along with 2 clients for own brand marketing globally ofRepublic of Yemen and Kenya. Our company has commenced manufacturing facility in year 2017, hence, our companyhas experience .... of more than 5 years in the current line of business of the company. as on the date of this Draft Red HerringProspectus our manufacturing facility at Curis Lifesciences Limited is installed with capacity to manufacture 138 Croretables / year, 15.75 Crore Capsules / year, 1080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45Tons sterile ophthalmic ointment / year. Our promoters have a vast experience in the pharmaceutical manufacturingIndustry. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, ourPromoters have been the pillars of our Company's growth and have built a strong value system for our Company. Withtheir enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical industry Read More
Address

P F-23, G I D C Sanand - I I Industrial Estate, Sanand

City

Ahmedabad

State

Gujarat

Pincode

382110

Phone

7096558558

Email

info@curisls.com

Website

www.curisls.com

About IPO

Listed At NSE
Lead Manager Finaax Capital Advisors Pvt Ltd
Promoters
Dharmesh Dashrathbhai Patel
Siddhant Jayantibhai Pawasia
Piyush Gordhanbhai Antala
Jaimik Mansukhbhai Patel

Promoter's Holding

Registrar

MUFG Intime India Pvt Ltd.

+91 810 811 8484
rnt.helpdesk@in.mpms.mufg.com
https://in.mpms.mufg.com/

Latest News

Aug
18
2026
COMPANY Posted on Aug 18th 2026

INDIGRID Infra Trust - Quaterly Results

The revenue zoomed 21.53% to Rs. 8454.04 millions for the quarter ended June 2026 as compared to Rs. 6956.16 millions during the corresponding quarter last year.A comparatively good net profit growth of 37.50% to Rs. 4643.79 millions was reported for the quarter ended June 2026 compared to Rs. 3377.19 millions of previous same quarter.Operating profit surged to 8650.02 millions from the corresponding previous quarter of 6998.50 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 8454.04 6956.16 21.53 8454.04 6956.16 21.53 31006.21 27200.01 13.99
Other Income 602.13 223.77 169.08 602.13 223.77 169.08 727.26 919.04 -20.87
PBIDT 8650.02 6998.50 23.60 8650.02 6998.50 23.60 29627.18 26853.43 10.33
Interest 3920.08 3615.15 8.43 3920.08 3615.15 8.43 15611.63 14020.61 11.35
PBDT 4729.94 3383.35 39.80 4729.94 3383.35 39.80 14015.55 12832.82 9.22
Depreciation 10.65 3.40 213.24 10.65 3.40 213.24 22.33 13.58 64.43
PBT 4719.29 3379.95 39.63 4719.29 3379.95 39.63 13993.22 12819.24 9.16
TAX 75.50 2.76 2635.51 75.50 2.76 2635.51 71.70 13.71 422.98
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 4643.79 3377.19 37.50 4643.79 3377.19 37.50 13921.52 12805.53 8.71
Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDTM(%) 102.32 100.61 1.70 102.32 100.61 1.70 95.55 98.73 -3.21
Read More
Aug
18
2026
COMPANY Posted on Aug 18th 2026

Shree Ram Proteins - Quaterly Results

The revenue slipped marginally during the June 2026 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2026 is Rs. -63.64 millions as compared to Net Loss of Rs. -18.19 millions of corresponding quarter ended June 2025 Operating profit Margin for the quarter ended June 2026 improved to 9.32% as compared to -16.83% of corresponding quarter ended June 2025
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 147.66 0.00
Other Income 14.02 0.14 9914.29 14.16 25.68 -44.86 25.54 3.43 644.61
PBIDT 9.32 -16.83 -155.38 -10.44 -40.52 -74.23 -169.38 -78.65 115.36
Interest 72.06 0.00 0.00 72.17 34.05 111.95 34.05 14.27 138.61
PBDT -62.74 -16.83 272.79 -129.76 -220.24 -41.08 -203.43 -92.92 118.93
Depreciation 0.88 1.41 -37.59 5.11 8.09 -36.84 6.69 8.21 -18.51
PBT -63.62 -18.24 248.79 -134.87 -228.33 -40.93 -210.12 -101.13 107.77
TAX 0.02 -0.05 -140.00 -0.13 0.58 -122.41 0.63 -5.29 -111.91
Deferred Tax 0.02 -0.05 -140.00 -0.13 0.58 -122.41 0.63 -5.29 -111.91
PAT -63.64 -18.19 249.86 -134.74 -228.91 -41.14 -210.75 -95.84 119.90
Equity 214.20 214.20 0.00 214.20 214.20 0.00 214.20 214.20 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -53.26 0.00
Read More
Aug
18
2026
COMPANY Posted on Aug 18th 2026

Interise Trust - Quaterly Results

A minor change in the total revenue was seen in the June 2026 quarter. The total revenue for the quarter stood at Rs. 3853.59 millions against Rs. 3733.06 millions during year ago period.Net profit stood at Rs. 2101.29  millions  compared to Rs. 1698.67 millions in the corresponding previous quarter,high by 23.70%.OP of the company witnessed a marginal growth to 3638.99 millions from 3392.33 millions in the same quarter last year.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202606 202506 % Var
Sales 3853.59 3733.06 3.23 3853.59 3733.06 3.23 3853.59 3733.06 3.23
Other Income 17.36 17.31 0.29 17.36 17.31 0.29 17.36 17.31 0.29
PBIDT 3638.99 3392.33 7.27 3638.99 3392.33 7.27 3638.99 3392.33 7.27
Interest 1530.54 1686.56 -9.25 1530.54 1686.56 -9.25 1530.54 1686.56 -9.25
PBDT 2108.45 1705.77 23.61 2108.45 1705.77 23.61 2108.45 1705.77 23.61
Depreciation 0.46 0.46 0.00 0.46 0.46 0.00 0.46 0.46 0.00
PBT 2107.99 1705.31 23.61 2107.99 1705.31 23.61 2107.99 1705.31 23.61
TAX 6.70 6.64 0.90 6.70 6.64 0.90 6.70 6.64 0.90
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2101.29 1698.67 23.70 2101.29 1698.67 23.70 2101.29 1698.67 23.70
Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDTM(%) 94.43 90.87 3.92 94.43 90.87 3.92 94.43 90.87 3.92
Read More
Aug
18
2026
COMPANY Posted on Aug 18th 2026

Brookfield IndiaReal - Quaterly Results

The Revenue for the quarter ended  June 2026 of Rs. 2227.81 millions grew by 9.84 % from Rs. 2028.23 millions.Profit after tax improved marginally to Rs. 1865.85  millions for the quarter ended June 2026 from Rs. 1840.84 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 2403.22 millions from 1964.70 millions in the same quarter last year.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2227.81 2028.23 9.84 2227.81 2028.23 9.84 0.00 0.00 0.00
Other Income 271.88 0.00 0.00 271.88 0.00 0.00 9888.48 8502.83 16.30
PBIDT 2403.22 1964.70 22.32 2403.22 1964.70 22.32 9570.94 8227.50 16.33
Interest 694.72 117.57 490.90 694.72 117.57 490.90 1106.57 712.52 55.30
PBDT 1708.50 1847.13 -7.51 1708.50 1847.13 -7.51 8464.37 7514.98 12.63
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 1708.50 1847.13 -7.51 1708.50 1847.13 -7.51 8464.37 7514.98 12.63
TAX -157.35 6.29 -2601.59 -157.35 6.29 -2601.59 315.61 370.44 -14.80
Deferred Tax -289.64 0.00 0.00 -289.64 0.00 0.00 175.90 302.97 -41.94
PAT 1865.85 1840.84 1.36 1865.85 1840.84 1.36 8148.76 7144.54 14.06
Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDTM(%) 107.87 96.87 11.36 107.87 96.87 11.36 0.00 0.00 0.00
Read More
Aug
18
2026
COMPANY Posted on Aug 18th 2026

IRBIT - Quaterly Results

Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended June 2026. The figure stood at Rs. 0.00 millions during the year-ago period.A good growth in profit of 33.75% reported to Rs. 7152.15  millions over Rs. 5347.39 millions of corresponding previous quarter.Operating profit for the quarter ended June 2026 rose to 9457.84 millions as compared to 7185.83 millions of corresponding quarter ended June 2025.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202606 202506 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 9405.80 6833.21 37.65 9405.80 6833.21 37.65 9405.80 6833.21 37.65
PBIDT 9457.84 7185.83 31.62 9457.84 7185.83 31.62 9457.84 7185.83 31.62
Interest 2305.69 1838.44 25.42 2305.69 1838.44 25.42 2305.69 1838.44 25.42
PBDT 7152.15 5347.39 33.75 7152.15 5347.39 33.75 7152.15 5347.39 33.75
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 7152.15 5347.39 33.75 7152.15 5347.39 33.75 7152.15 5347.39 33.75
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7152.15 5347.39 33.75 7152.15 5347.39 33.75 7152.15 5347.39 33.75
Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Curis Lifesciences Ltd. IPO?

The issue size of Curis Lifesciences Ltd. IPO is ₹18.49 - 19.72 crore.

The Curis Lifesciences Ltd. IPO opens for subscription on 2025-11-07 and closes on 2025-11-11.

The price range of Curis Lifesciences Ltd. IPO is ₹120.00 to ₹128.00.

The lot size of Curis Lifesciences Ltd. IPO is 2000 shares.

The registrar of Curis Lifesciences Ltd. IPO is MUFG Intime India Pvt Ltd..

Curis Lifesciences Ltd. IPO will be listed on NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2025-11-11 to increase your chances.

The listing date of Curis Lifesciences Ltd. IPO is 2025-11-14.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore